Clinical Trial Update: Preventing Postpartum Depression With Intranasal Oxytocin [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intranasal oxytocin to prevent postpartum depression has completed, with results posted. The study also collected data on anxiety sympt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder
• Postpartum Depression

Drugs mentioned

• Oxytocin (intranasal) (oxytocin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Depression, Postpartum, Anxiety | Phase 2 | Status: COMPLETED | Results posted: 2025-02-25